These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 27816489)
1. PKCθ-induced phosphorylations control the ability of Fra-1 to stimulate gene expression and cancer cell migration. Belguise K; Cherradi S; Sarr A; Boissière F; Boulle N; Simony-Lafontaine J; Choesmel-Cadamuro V; Wang X; Chalbos D Cancer Lett; 2017 Jan; 385():97-107. PubMed ID: 27816489 [TBL] [Abstract][Full Text] [Related]
2. The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells. Belguise K; Milord S; Galtier F; Moquet-Torcy G; Piechaczyk M; Chalbos D Oncogene; 2012 Nov; 31(47):4889-97. PubMed ID: 22286759 [TBL] [Abstract][Full Text] [Related]
3. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells. Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795 [TBL] [Abstract][Full Text] [Related]
4. Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Chen H; Zhu G; Li Y; Padia RN; Dong Z; Pan ZK; Liu K; Huang S Cancer Res; 2009 Dec; 69(24):9228-35. PubMed ID: 19920183 [TBL] [Abstract][Full Text] [Related]
5. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas. Milde-Langosch K; Röder H; Andritzky B; Aslan B; Hemminger G; Brinkmann A; Bamberger CM; Löning T; Bamberger AM Breast Cancer Res Treat; 2004 Jul; 86(2):139-52. PubMed ID: 15319566 [TBL] [Abstract][Full Text] [Related]
6. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Belguise K; Kersual N; Galtier F; Chalbos D Oncogene; 2005 Feb; 24(8):1434-44. PubMed ID: 15608675 [TBL] [Abstract][Full Text] [Related]
7. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition. Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173 [TBL] [Abstract][Full Text] [Related]
8. Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion. Annis MG; Ouellet V; Rennhack JP; L'Esperance S; Rancourt C; Mes-Masson AM; Andrechek ER; Siegel PM Breast Cancer Res; 2018 Jan; 20(1):9. PubMed ID: 29382358 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells. Kimura R; Ishikawa C; Rokkaku T; Janknecht R; Mori N Biochim Biophys Acta; 2011 Aug; 1813(8):1543-53. PubMed ID: 21640141 [TBL] [Abstract][Full Text] [Related]
11. Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis. Hanson RL; Brown RB; Steele MM; Grandgenett PM; Grunkemeyer JA; Hollingsworth MA Oncotarget; 2016 Jun; 7(26):39996-40011. PubMed ID: 27220889 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties. Oliveira-Ferrer L; Kürschner M; Labitzky V; Wicklein D; Müller V; Lüers G; Schumacher U; Milde-Langosch K; Schröder C J Cancer Res Clin Oncol; 2015 Oct; 141(10):1715-26. PubMed ID: 25666264 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene. Yang J; Zhang Z; Chen C; Liu Y; Si Q; Chuang TH; Li N; Gomez-Cabrero A; Reisfeld RA; Xiang R; Luo Y Oncogene; 2014 Jun; 33(23):3014-23. PubMed ID: 23831570 [TBL] [Abstract][Full Text] [Related]
15. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells. Wu J; Ji A; Wang X; Zhu Y; Yu Y; Lin Y; Liu Y; Li S; Liang Z; Xu X; Zheng X; Xie L J Transl Med; 2015 Sep; 13():289. PubMed ID: 26337460 [TBL] [Abstract][Full Text] [Related]
17. Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells. Chao CY; Lii CK; Hsu YT; Lu CY; Liu KL; Li CC; Chen HW Carcinogenesis; 2013 Aug; 34(8):1843-51. PubMed ID: 23615401 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Yang S; Li Y; Gao J; Zhang T; Li S; Luo A; Chen H; Ding F; Wang X; Liu Z Oncogene; 2013 Sep; 32(36):4294-303. PubMed ID: 23001043 [TBL] [Abstract][Full Text] [Related]
19. Dual role for mitogen-activated protein kinase (Erk) in insulin-dependent regulation of Fra-1 (fos-related antigen-1) transcription and phosphorylation. Hurd TW; Culbert AA; Webster KJ; Tavaré JM Biochem J; 2002 Dec; 368(Pt 2):573-80. PubMed ID: 12197835 [TBL] [Abstract][Full Text] [Related]
20. Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer. Zhao C; Qiao Y; Jonsson P; Wang J; Xu L; Rouhi P; Sinha I; Cao Y; Williams C; Dahlman-Wright K Cancer Res; 2014 Jul; 74(14):3983-94. PubMed ID: 24830720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]